← Back to Analyst Consensus 
KROS Buy
Keros Therapeutics, Inc.
Current Price —
Implied Upside —
Analysts 13
30-Day Momentum
▲ 0 upgrades / ▼ 0 downgrades / 0 reiterations from 0 firms
Next Earnings
Nov 11, 2026 (16 days)
Rating Timeline
| Date ▼ | Firm | Action | From → To Rating | Price Target | Firm Rating |
|---|---|---|---|---|---|
| Aug 4, 2026 | Wells Fargo | maintain | Overweight → Overweight | — | 54% |
| Aug 4, 2026 | Leerink Partners | maintain | Outperform → Outperform | — | 51% |
| Mar 5, 2026 | Wells Fargo | maintain | Overweight → Overweight | — | 54% |
| Nov 28, 2025 | B of A Securities | maintain | Neutral → Neutral | $19 | 53% |
| Nov 12, 2025 | Oppenheimer | reiterate | Outperform → Outperform | $27 | 52% |
| Nov 11, 2025 | Wells Fargo | maintain | Overweight → Overweight | $23 | 54% |
| Nov 6, 2025 | Wedbush | maintain | Neutral → Neutral | $16 | 58% |
| Aug 8, 2025 | HC Wainwright & Co. | maintain | Buy → Buy | $20 | 44% |
| Jun 10, 2025 | B of A Securities | downgrade | Buy → Neutral | $18 | 53% |
| May 30, 2025 | Wedbush | reiterate | Neutral → Neutral | $15 | 58% |
| May 12, 2025 | Scotiabank | maintain | Sector Outperform → Sector Outperform | $26 | 55% |
| May 8, 2025 | HC Wainwright & Co. | maintain | Buy → Buy | $25 | 44% |
| Apr 9, 2025 | Truist Securities | maintain | Buy → Buy | $25 | 54% |
| Apr 1, 2025 | Wedbush | reiterate | Neutral → Neutral | $15 | 58% |
| Apr 1, 2025 | HC Wainwright & Co. | reiterate | Buy → Buy | $40 | 44% |
| Feb 27, 2025 | Wells Fargo | maintain | Overweight → Overweight | $26 | 54% |
| Feb 27, 2025 | HC Wainwright & Co. | maintain | Buy → Buy | $40 | 44% |
| Jan 21, 2025 | Cantor Fitzgerald | downgrade | Overweight → Neutral | $0 | 50% |
| Jan 17, 2025 | Piper Sandler | maintain | Overweight → Overweight | $15 | 54% |
| Jan 17, 2025 | Wedbush | downgrade | Outperform → Neutral | $15 | 58% |
| Jan 17, 2025 | Guggenheim | reiterate | Neutral → Neutral | $0 | 52% |
| Jan 16, 2025 | Scotiabank | maintain | Sector Outperform → Sector Outperform | $41 | 55% |
| Jan 16, 2025 | Oppenheimer | maintain | Outperform → Outperform | $23 | 52% |
| Dec 23, 2024 | Truist Securities | maintain | Buy → Buy | $43 | 54% |
| Dec 16, 2024 | Oppenheimer | maintain | Outperform → Outperform | $63 | 52% |
| Dec 16, 2024 | Guggenheim | downgrade | Buy → Neutral | $0 | 52% |
| Dec 13, 2024 | Scotiabank | maintain | Sector Outperform → Sector Outperform | $44 | 55% |
| Dec 13, 2024 | Wells Fargo | maintain | Overweight → Overweight | $28 | 54% |
| Dec 13, 2024 | HC Wainwright & Co. | reiterate | Buy → Buy | $47 | 44% |
| Dec 12, 2024 | William Blair | downgrade | Outperform → Market Perform | $0 | 48% |
| Dec 12, 2024 | TD Cowen | downgrade | Buy → Hold | $0 | 54% |
| Dec 12, 2024 | BTIG | downgrade | Buy → Neutral | $0 | 52% |
| Dec 11, 2024 | Wells Fargo | maintain | Overweight → Overweight | $111 | 54% |
| Dec 5, 2024 | Guggenheim | maintain | Buy → Buy | $102 | 52% |
| Dec 4, 2024 | Guggenheim | reiterate | Buy → Buy | $0 | 52% |
| Nov 22, 2024 | Cantor Fitzgerald | reiterate | — → Overweight | $0 | 50% |
| Nov 7, 2024 | HC Wainwright & Co. | reiterate | Buy → Buy | $100 | 44% |
| Oct 24, 2024 | Cantor Fitzgerald | reiterate | — → Overweight | $0 | 50% |
| Oct 16, 2024 | Scotiabank | initiate | — → Sector Outperform | $77 | 55% |
| Sep 23, 2024 | Guggenheim | initiate | — → Buy | $96 | 52% |
| Sep 12, 2024 | B of A Securities | maintain | Buy → Buy | $76 | 53% |
| Jun 25, 2024 | Oppenheimer | initiate | — → Outperform | $102 | 52% |
| Jun 18, 2024 | Truist Securities | maintain | Buy → Buy | $100 | 54% |
| Jun 18, 2024 | HC Wainwright & Co. | reiterate | Buy → Buy | $100 | 44% |
| May 9, 2024 | HC Wainwright & Co. | reiterate | Buy → Buy | $100 | 44% |
| Mar 27, 2024 | Piper Sandler | maintain | Overweight → Overweight | $105 | 54% |
| Mar 13, 2024 | Truist Securities | reiterate | Buy → Buy | $100 | 54% |
| Mar 1, 2024 | HC Wainwright & Co. | reiterate | Buy → Buy | $100 | 44% |
| Dec 8, 2023 | Wells Fargo | initiate | — → Overweight | $60 | 54% |
| Nov 13, 2023 | Wedbush | reiterate | Outperform → Outperform | $86 | 58% |
Price Target Trend
May 19, 2026 Oct 26, 2026
EPS Estimates
+1y —
0y —
+1q —
0q —
Cross-Platform Signals
No cross-platform signals in the last 90 days